Farallon Capital Management’s AbbVie ABBV Stock Holding History

Farallon Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-939,212	Closed	-$152M	–	194
2022 Q4	$152M	Buy	939,212 +214,100	+30%	+$32.8M	0.9%	39
2022 Q3	$97.3M	Buy	725,112 +219,597	+43%	+$31.5M	0.53%	52
2022 Q2	$77.4M	Sell	505,515 -639,152	-56%	-$97.7M	0.42%	61
2022 Q1	$186M	Sell	1,144,667 -463,784	-29%	-$67.4M	0.9%	34
2021 Q4	$218M	Buy	1,608,451 +1,126,603	+234%	+$133M	1.09%	29
2021 Q3	$52M	Buy	+481,848	New	+$55.1M	0.24%	73
2021 Q1	–	Sell	-1,150,000	Closed	-$123M	–	238
2020 Q4	$123M	Sell	1,150,000 -3,100,000	-73%	-$298M	0.74%	43
2020 Q3	$372M	Buy	4,250,000 +100,000	+2%	+$9.41M	2.57%	10
2020 Q2	$407M	Buy	4,150,000 +150,000	+4%	+$13.2M	3.26%	5
2020 Q1	$305M	Buy	4,000,000 +1,500,000	+60%	+$128M	2.62%	10
2019 Q4	$221M	Buy	2,500,000 +1,500,000	+150%	+$125M	1.49%	23
2019 Q3	$75.7M	Buy	+1,000,000	New	+$68.6M	0.57%	42
2018 Q1	–	Sell	-700,000	Closed	-$67.7M	–	87
2017 Q4	$67.7M	Buy	700,000 +115,000	+20%	+$10.8M	0.55%	36
2017 Q3	$52M	Sell	585,000 -250,000	-30%	-$19M	0.46%	45
2017 Q2	$60.5M	Buy	+835,000	New	+$56.1M	0.63%	33
2017 Q1	–	Sell	-160,000	Closed	-$10M	–	73
2016 Q4	$10M	Buy	+160,000	New	+$9.77M	0.12%	55
2015 Q4	–	Sell	-722,000	Closed	-$39.3M	–	68
2015 Q3	$39.3M	Buy	722,000 +437,000	+153%	+$28.4M	0.52%	44
2015 Q2	$19.1M	Buy	+285,000	New	+$18.6M	0.26%	53

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Farallon Capital Management's ABBV Position: Q1 2023 in Review

Farallon Capital Management sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 939,212 shares — an estimated $152M sold.

Farallon Capital Management first reported a position in ABBV in Q2 2015 and held it in 18 quarters. The position peaked at $407M in Q2 2020. 3,138 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

Farallon Capital Management reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
Farallon Capital Management sold 939,212 AbbVie shares in Q1 2023, an estimated $152M.
Farallon Capital Management first reported a position in AbbVie in Q2 2015 and held it in 18 quarters.
Farallon Capital Management's AbbVie position peaked at $407M in Q2 2020.
3,138 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Farallon Capital Management's 13F filing for Q1 2023, filed 15 May 2023.